Diagnosing breast cancer tumors using stacked ensemble model

Author(s):  
Ahmet Haşim Yurttakal ◽  
Hasan Erbay ◽  
Türkan İkizceli ◽  
Seyhan Karaçavuş ◽  
Cenker Biçer

Breast cancer is the most common cancer that progresses from cells in the breast tissue among women. Early-stage detection could reduce death rates significantly, and the detection-stage determines the treatment process. Mammography is utilized to discover breast cancer at an early stage prior to any physical sign. However, mammography might return false-negative, in which case, if it is suspected that lesions might have cancer of chance greater than two percent, a biopsy is recommended. About 30 percent of biopsies result in malignancy that means the rate of unnecessary biopsies is high. So to reduce unnecessary biopsies, recently, due to its excellent capability in soft tissue imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) has been utilized to detect breast cancer. Nowadays, DCE-MRI is a highly recommended method not only to identify breast cancer but also to monitor its development, and to interpret tumorous regions. However, in addition to being a time-consuming process, the accuracy depends on radiologists’ experience. Radiomic data, on the other hand, are used in medical imaging and have the potential to extract disease characteristics that can not be seen by the naked eye. Radiomics are hard-coded features and provide crucial information about the disease where it is imaged. Conversely, deep learning methods like convolutional neural networks(CNNs) learn features automatically from the dataset. Especially in medical imaging, CNNs’ performance is better than compared to hard-coded features-based methods. However, combining the power of these two types of features increases accuracy significantly, which is especially critical in medicine. Herein, a stacked ensemble of gradient boosting and deep learning models were developed to classify breast tumors using DCE-MRI images. The model makes use of radiomics acquired from pixel information in breast DCE-MRI images. Prior to train the model, radiomics had been applied to the factor analysis to refine the feature set and eliminate unuseful features. The performance metrics, as well as the comparisons to some well-known machine learning methods, state the ensemble model outperforms its counterparts. The ensembled model’s accuracy is 94.87% and its AUC value is 0.9728. The recall and precision are 1.0 and 0.9130, respectively, whereas F1-score is 0.9545.

2020 ◽  
Author(s):  
Xuan Shao ◽  
Xiao Yan Jin ◽  
Zhi Gang Chen ◽  
Zhi Gang Zhang ◽  
Ke Wang ◽  
...  

Abstract Background Previous study has reported that circulating tumor cells (CTCs) could serve as a diagnostic biomarker in breast cancer (BC) screening. However, the differential efficacy of routine examination including ultrasound (US), mammogram (MG), magnetic resonance imaging (MR), and breast-specific gamma imaging (BSGI) and CTCs is unknown. This study aimed to combine CTCs with other BC screening imaging modalities to screen for cancer and enhance diagnostic potency in non-metastatic BC patients. Methods 102 treatment-naive non-metastatic BC patients were enrolled in this study between December 2017 and November 2018. All these patients received CTC detection and at least one medical imaging examination. Correlations of CTC enumeration with patients’ clinicopathological characteristics and medical imaging examinations were evaluated. Results CTC detection rates (average CTC counts) in stage I-III BC patients were 92.9% (2.1), 87.2% (2.4) and 100% (4.2), respectively. CTCs counts were positively associated with cancer stage (p = 0.0084) and tumor size (p = 0.0301). CTCs counts were more correlated with US than MR, and showed least correlation with MG. CTCs counts were not associated with molecular subtypes of BC nor breast-specific gamma imaging (BSGI) results, indicating that CTC enumeration cannot be used to reflect molecular signatures of BC. When both cut-off values for CTCs and Breast Imaging-Reporting and Data System (BI-RADS) were used, false negative rates (FNR) of CTCs, US, MG and MR in BC detection in this study were 22.5%, 15.8%, 30.6% and 12.8%, respectively. Combination of CTC with US, MG or MR decreased FNR of BC detection to 7.9%, 8.3% and 5.8%, respectively. False negatives are more common in early stage patients, and in patients with smaller tumors. Conclusion CTCs counts can be used as a diagnostic aid in BC screening and early diagnosis. CTCs counts were more relevant to US than MR or MG. Conjugation of CTCs counts would improve the diagnostic potency of medical imaging examinations for BC detection, especially for MG in Chinese women.


Author(s):  
Antonios Matzakos Chorianopoulos ◽  
Ioannis Daramouskas ◽  
Isidoros Perikos ◽  
Foteini Grivokostopoulou ◽  
Ioannis Hatzilygeroudis

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2764
Author(s):  
Xin Yu Liew ◽  
Nazia Hameed ◽  
Jeremie Clos

A computer-aided diagnosis (CAD) expert system is a powerful tool to efficiently assist a pathologist in achieving an early diagnosis of breast cancer. This process identifies the presence of cancer in breast tissue samples and the distinct type of cancer stages. In a standard CAD system, the main process involves image pre-processing, segmentation, feature extraction, feature selection, classification, and performance evaluation. In this review paper, we reviewed the existing state-of-the-art machine learning approaches applied at each stage involving conventional methods and deep learning methods, the comparisons within methods, and we provide technical details with advantages and disadvantages. The aims are to investigate the impact of CAD systems using histopathology images, investigate deep learning methods that outperform conventional methods, and provide a summary for future researchers to analyse and improve the existing techniques used. Lastly, we will discuss the research gaps of existing machine learning approaches for implementation and propose future direction guidelines for upcoming researchers.


2019 ◽  
Vol 132 ◽  
pp. 103985 ◽  
Author(s):  
Xiaohui Zhang ◽  
Yaoyun Zhang ◽  
Qin Zhang ◽  
Yuankai Ren ◽  
Tinglin Qiu ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2767
Author(s):  
Jiawei Li ◽  
Xin Guan ◽  
Zhimin Fan ◽  
Lai-Ming Ching ◽  
Yan Li ◽  
...  

Breast cancer is the most common cancer in women worldwide. Accurate early diagnosis of breast cancer is critical in the management of the disease. Although mammogram screening has been widely used for breast cancer screening, high false-positive and false-negative rates and radiation from mammography have always been a concern. Over the last 20 years, the emergence of “omics” strategies has resulted in significant advances in the search for non-invasive biomarkers for breast cancer diagnosis at an early stage. Circulating carcinoma antigens, circulating tumor cells, circulating cell-free tumor nucleic acids (DNA or RNA), circulating microRNAs, and circulating extracellular vesicles in the peripheral blood, nipple aspirate fluid, sweat, urine, and tears, as well as volatile organic compounds in the breath, have emerged as potential non-invasive diagnostic biomarkers to supplement current clinical approaches to earlier detection of breast cancer. In this review, we summarize the current progress of research in these areas.


2015 ◽  
Vol 18 (4) ◽  
pp. 541-546 ◽  
Author(s):  
Louis P. Garrison ◽  
Joseph B. Babigumira ◽  
Anthony Masaquel ◽  
Bruce C.M. Wang ◽  
Deepa Lalla ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document